Skip to main navigation
Skip to search
Skip to main content
Sort by
Immunology and Microbiology
Infection
100%
Infectious Disease
99%
In Vitro
60%
Minimum Inhibitory Concentration
36%
Susceptibility
29%
Antifungal Susceptibility
29%
Infectious Agent
22%
Mould
20%
Aspergillus
20%
Candida Albicans
20%
Candida
19%
Lung
17%
Aspergillosis
16%
Aspergillus fumigatus
15%
Coccidioides
15%
Fusarium
13%
Antifungal Resistance
13%
Immunocompromised Patient
13%
Candida Auris
12%
Fusarium solani
11%
Broth Dilution
10%
Antifungal Activity
10%
New Species
9%
Filamentous Fungus
9%
Cryptococcus neoformans
9%
Drug Megadose
9%
Pharmacodynamics
8%
Morphology
8%
Sterol
8%
Terbinafine
8%
Biofilm
8%
Scedosporium
7%
Rhizopus oryzae
7%
Fungi
7%
DNA Sequence
7%
Mucorales
7%
Cladistics
7%
Fusarium oxysporum
6%
Species Identification
6%
Candida Glabrata
6%
Cryptococcus gattii
6%
Morbidity
6%
Filobasidiella
6%
Dermatophyte
6%
Fungus Identification
6%
Mouse Model
6%
Time-of-Flight Mass Spectrometry
5%
Species Distribution
5%
Colony-Forming Unit
5%
Inoculum
5%
Pharmacology, Toxicology and Pharmaceutical Science
Echinocandin
36%
Infection
30%
Antifungal Agent
25%
Candida
23%
Voriconazole
23%
Fluconazole
21%
Amphotericin B
20%
Caspofungin
20%
Invasive Aspergillosis
19%
Candida glabrata
18%
Pharmacokinetics
17%
Candida Albicans
17%
Mycosis
16%
Pyrrole
16%
Pharmacodynamics
16%
Isavuconazole
15%
Posaconazole
15%
Invasive Candidiasis
14%
Aspergillus
14%
Systemic Mycosis
14%
Resistance to Antifungal Agent
13%
Mucormycosis
12%
Triazole
12%
Pyrrole Derivative
11%
Coccidioides
10%
Itraconazole
10%
Aspergillus fumigatus
9%
Rezafungin
9%
Coccidioidomycosis
8%
Mould
8%
Micafungin
8%
Diseases
8%
Anidulafungin
7%
Infectious Agent
7%
Ibrexafungerp
7%
Placebo
7%
Antifungal Activity
6%
Rhizopus arrhizus
6%
Candida Auris
6%
Polyenes
6%
Olorofim
5%
Fungi
5%
Tetrazole Derivative
5%
Therapeutic Drug Monitoring
5%
Triazole Derivative
5%
Repurposing
5%
Glucan
5%
Candidiasis
5%
Antiinfective Agent
5%
Clinical Trial
5%
Medicine and Dentistry
Infection
11%
Antifungal Susceptibility
7%
Invasive Aspergillosis
6%
Mycosis
5%
Infectious Disease
5%
Histoplasmosis
5%
Acute Myeloid Leukemia
5%